Application of genomic technologies in clinical pharmacology research

Rafael Baltazar Reyes Leon-Cachon, Jorge Angel Isloro Ascacio-Martinez, Magdalena Gomez-Silva, Everardo Pilieyro-Garza, Jos Gerardo Gonzalez-Gonzalez, Gregory Pogue, Laureano Simôn-Buela, Hugo Alberto Barrera-Saldaea

    Research output: Contribution to journalReview articlepeer-review

    4 Citations (Scopus)

    Abstract

    Technology is the basis of scientific progress and is an essential component for continued competitiveness in industry. The development of a new drug candidate is a long and expensive process, in which a molecule undergoes several stages of research (both pre-clinical and clinical) before being approved for commercialization. Scientific progress has revolutionized the pharmaceutical industry and reshaped the processes by which new drugs are discovered, investigated, and developed. Currently, the influence of genomic variations in drug metabolism must be better understood to predict an individual's response to a given treatment. Employing genomics tools, an individual's genetic profile may be obtained and used as the basis for prescription of the best treatment option, thus personalizing medicine. In this review, we discuss how current mainstream genomic technologies used in clinical pharmacology research can accelerate the identification of populations that can benefit the most while reducing adverse events. (REV INVES dIN. 2015;67:212-8).
    Original languageEnglish
    Pages (from-to)212-218
    Number of pages7
    JournalRevista de Investigacion Clinica
    Volume67
    Issue number4
    Publication statusPublished - 1 Jan 2015

    All Science Journal Classification (ASJC) codes

    • General Medicine

    Fingerprint

    Dive into the research topics of 'Application of genomic technologies in clinical pharmacology research'. Together they form a unique fingerprint.

    Cite this